Amantadine-associated Corneal Edema

Ophthalmology

Volumn 116, Issue 6, 2009, Pages 1230-1231

  Naumann, Gottfried O H ^a   Schlötzer Schrehardt, Ursula ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE;

CONGENITAL CORNEA DYSTROPHY; CORNEA EDEMA; HUMAN; KERATOPATHY; LETTER; PRIORITY JOURNAL; PSEUDOEXFOLIATION;

AMANTADINE; ANALGESICS, NON-NARCOTIC; BIPOLAR DISORDER; CORNEAL EDEMA; DOPAMINE AGENTS; HUMANS; KERATOPLASTY, PENETRATING; MULTIPLE SCLEROSIS; VISUAL ACUITY;

EID: 66049143450     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.01.006     Document Type: Letter

References (5)

1. Jeng B.H., Galor A., Lee M.S., et al. Amantadine-associated corneal edema: potentially irreversible even after cessation of the medication. Ophthalmology 115 (2008) 1540-1544
2. French D.D., and Margo C.E. Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration. Cornea 26 (2007) 1087-1089
3. Schlötzer-Schrehardt U., Dörfler S., and Naumann G.O. Corneal endothelial involvement in pseudoexfoliation syndrome. Arch Ophthalmol 111 (1993) 666-674
4. Naumann G.O., and Schlötzer-Schrehardt U. Keratopathy in pseudoexfoliation syndrome as a cause of corneal endothelial decompensation: a clinicopathologic study. Ophthalmology 107 (2000) 1111-1124
5. Schlötzer-Schrehardt U., and Naumann G.O. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141 (2006) 921-937